Richard Capasso - 30 Jun 2022 Form 4 Insider Report for SQZ Biotechnologies Co

Role: Officer Title - Principal Accounting Officer and Chief Accounting Officer
Signature: /s/ Lawrence Knopf, Attorney-in-Fact for Richard Capasso
Issuer symbol: N/A
Transactions as of: 30 Jun 2022
Net transactions value: +$3,198
Form type: 4
Filing time: 05 Jul 2022, 17:00:24 UTC
Previous filing: 15 Feb 2022
Next filing: 16 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SQZB	Common Stock	Award	$3,198	+1,183		$2.70^*	1,183	30 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is voluntarily reporting the acquisition on June 30, 2022 of 1,183 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan.

Remarks:

Officer Title - Principal Accounting Officer and Chief Accounting Officer